Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrich M Lauer

Showing results (61-70 of 142) with videos related to

Pageof 15
Sort By:
Journal of Virological Methods|March 1, 2003
Cell cycle independent infection and gene transfer by recombinant Sendai virusesSorin Armeanu, Guy Ungerechts, Christian Bernloehr, et al.
Viruses|February 27, 2026
Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734Fiona D Nitschke, Julia Beil, Irina Smirnow, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
BMC Cancer|December 5, 2019
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapyChihab Klose, Susanne Berchtold, Marina Schmidt, et al.
Cancer Cell International|October 11, 2022
Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapySimon Heumos, Sandra Dehn, Konstantin Bräutigam, et al.
BMC Cancer|June 30, 2009
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenibMarius Horger, Ulrich M Lauer, Christina Schraml, et al.
Frontiers in Immunology|May 1, 2023
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancerMartina S Lutz, Latifa Zekri, Laura Weßling, et al.
World Journal of Gastroenterology|September 28, 2016
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12Christoph R Werner, Julia M Schwarz, Daniel P Egetemeyr, et al.
Pageof 15

Showing results (61-70 of 142) with videos related to

Sort By:
Pageof 15
Journal of Virological Methods|March 1, 2003
Cell cycle independent infection and gene transfer by recombinant Sendai virusesSorin Armeanu, Guy Ungerechts, Christian Bernloehr, et al.
Viruses|February 27, 2026
Enhanced Antitumor Activity and Induction of Immunogenic Cell Death in NUT Carcinoma Cells by Combining Oncolytic Viruses with the Dual Inhibitor NEO2734Fiona D Nitschke, Julia Beil, Irina Smirnow, et al.
Virology Journal|April 19, 2015
First-generation protease inhibitor-triple therapy: SVR 24, safety, and predictors of response in a large single center cohortChristoph R Werner, Carolin Franz, Daniel P Egetemeyr, et al.
Plos One|November 23, 2013
Feasibility of telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: SVR 24 resultsChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 4, 2012
Telaprevir-based triple therapy in liver transplant patients with hepatitis C virus: a 12-week pilot study providing safety and efficacy dataChristoph R Werner, Daniel P Egetemeyr, Ulrich M Lauer, et al.
BMC Cancer|December 5, 2019
Biological treatment of pediatric sarcomas by combined virotherapy and NK cell therapyChihab Klose, Susanne Berchtold, Marina Schmidt, et al.
Cancer Cell International|October 11, 2022
Multiomics surface receptor profiling of the NCI-60 tumor cell panel uncovers novel theranostics for cancer immunotherapySimon Heumos, Sandra Dehn, Konstantin Bräutigam, et al.
BMC Cancer|June 30, 2009
Early MRI response monitoring of patients with advanced hepatocellular carcinoma under treatment with the multikinase inhibitor sorafenibMarius Horger, Ulrich M Lauer, Christina Schraml, et al.
Frontiers in Immunology|May 1, 2023
IgG-based B7-H3xCD3 bispecific antibody for treatment of pancreatic, hepatic and gastric cancerMartina S Lutz, Latifa Zekri, Laura Weßling, et al.
World Journal of Gastroenterology|September 28, 2016
Second-generation direct-acting-antiviral hepatitis C virus treatment: Efficacy, safety, and predictors of SVR12Christoph R Werner, Julia M Schwarz, Daniel P Egetemeyr, et al.
Pageof 15